Polio eradication: Addressing the hurdles on the last mile

Kimberly M Thompson; Adam S Lauring; Andrew J Pollard; Raul Andino; Ananda S Bandyopadhyay; Seth Berkley; Zulfiqar Ahmed Bhutta; Janell Routh; Christine Stabell Benn

doi:10.1016/j.cell.2022.12.021

Polio eradication: Addressing the hurdles on the last mile

Cell. 2023 Jan 5;186(1):1-4. doi: 10.1016/j.cell.2022.12.021.

Authors

Kimberly M Thompson, Adam S Lauring, Andrew J Pollard, Raul Andino, Ananda S Bandyopadhyay, Seth Berkley, Zulfiqar Ahmed Bhutta, Janell Routh, Christine Stabell Benn

PMID: 36608647
DOI: 10.1016/j.cell.2022.12.021

Abstract

1988, the World Health Assembly committed to eradicate poliomyelitis, a viral disease that can cause permanent paralysis. Today, only type 1 of the three wild poliovirus types remains circulating in limited geographic areas following widespread use of different poliovirus vaccines. While we are close to zero new cases of wild polio, it is a fragile situation, and there are many remaining and new hurdles to overcome. Here, experts discuss how to address them.

MeSH terms

Disease Eradication
Global Health
Humans
Poliomyelitis* / epidemiology
Poliomyelitis* / prevention & control
Poliovirus Vaccines*
Poliovirus*

Substances

Poliovirus Vaccines